Cost-Effectiveness Analysis of Oral Fentanyl Formulations for Breakthrough Cancer Pain Treatment

Value in Health- United Kingdom

doi 10.1016/j.jval.2016.09.2216

Full Text

Abstract

Available in

Categories

Occupational Health

Date

November 1, 2016

Authors

LS D'Angiolella

Publisher

Elsevier BV

Related search

Budget Impact Analysis of the Fentanyl Buccal Tablet for Treatment of Breakthrough Cancer Pain

ClinicoEconomics and Outcomes Research

English

Intranasal Fentanyl for Breakthrough Pain Control

Clinical Medicine Insights: Therapeutics

Pharmaceutical Science

English

Role of Intranasal Fentanyl in Breakthrough Pain Management in Cancer Patients

Cancer Management and Research

English

A New Fast-Acting Sublingual Fentanyl (Recivit®) for Treating Breakthrough Cancer Pain

European Oncology and Haematology

English

Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation

Circulation. Cardiovascular quality and outcomes

Cardiovascular Medicine

English

Evidence-Based Treatment of Cancer-Related Breakthrough Pain With Opioids

Journal of the National Comprehensive Cancer Network : JNCCN

English

Cn8 - Cost-Effectiveness Analysis of Oral Cancer Screening in Taiwan: A Real World Data Analysis

Value in Health

Occupational Health

English

Canadian Recommendations for the Management of Breakthrough Cancer Pain

Current Oncology

English

Response to Oral Immediate‐Release Opioids for Breakthrough Pain in Patients With Advanced Cancer With Adequately Controlled Background Pain

Cancer Research

English